猪繁殖与呼吸综合征病毒非结构蛋白NSP2的原核表达及其单克隆抗体的研制

将猪繁殖与呼吸综合征病毒(PRRSV)S1株NSP2蛋白基因进行截短修饰 (tNSP2),克隆于pGEX-6P-1载体,转化大肠杆菌后用IPTG诱导表达。Western-blot结果表明,融合表达的GST-tNSP2蛋白能被PRRSV阳性血清特异性识别,大小约50kD。经GST柱提取纯化蛋白GST- tNSP2,免疫BALB/c小鼠,取脾细胞与SP2/0骨髓瘤细胞进行融合,获得2株能稳定分泌抗NSP2蛋白抗体的杂交瘤细胞株,将其命名为2B5、3H3。亚型鉴定结果均为IgG 1型,其轻链均为Κ链。间接免疫荧光试验证明,2B5和3H3均能与PRRSV S1毒株产生特异性反应,而不能与SY0608毒株反应。从而为PRRSV分离株的鉴定及NSP2功能研究奠定了重要基础。     

人免疫缺陷病毒I型Vif蛋白的原核表达、纯化及单克隆抗体制备

目的：克隆、表达、纯化人免疫缺陷病毒I型（HIV-1）Vif蛋白,制备其单克隆抗体。方法：提取感染了HIV的细胞基因组DNA,PCR扩增vif基因,插入表达载体pET32a,转化大肠杆菌BL21（DE3）获得工程菌株,IPTG诱导蛋白表达,Western印迹鉴定目的蛋白,亲和层析纯化目的蛋白;免疫BALB／c小鼠,制备单克隆抗体。结果：构建了Vif蛋白的原核表达载体vif-pET32a,并在大肠杆菌中获得高表达,目的蛋白以包涵体形式存在;纯化获得高纯度的重组Vif蛋白,蛋白浓度可达0．56mg／mL;建立了抗Vif蛋白单克隆抗体细胞株,制备了腹水,滴度可达1：16×10^6,抗体纯化后保持了活性和特异性。结论：在原核表达系统中表达、纯化了重组Vif蛋白,制备了针对Vif蛋白的单克隆抗体,为研究Vif蛋白的功能和抗原性奠定了基础。     

口蹄疫病毒非结构蛋白3abc基因的克隆与表达

口蹄疫病毒(Foot-and-mouth disease virus , FMDV)非结构蛋白(NSP)-3ABC可用于注苗与感染动物的鉴别诊断,合成该基因的PCR引物,并在引物5' 端和3' 端分别加入含BamH I和Hind III限制性酶切位点序列.以FMDV毒株基因组RNA为模板,利用RT-PCR技术扩增3abc基因,得到的基因片段与T载体连接,转化DH5α.提取重组载体pT-3ABC,经BamH I/Hind III双酶切后与载体pET32a连接,转化宿主菌BL21(DE3)plysS,IPTG诱导表达目的蛋白.SDS-PAGE及Western Blotting检测和鉴定结果表明,在大肠杆菌中成功表达了NSP-3ABC蛋白,分子量约56kDa,且该表达产物可与FMDV感染的动物血清产生免疫反应.ELISA试验结果显示,表达蛋白可用于FMDV注苗与感染动物的鉴别诊断.     

FMDV非结构蛋白2C主要表位区与3AB基因的组合表达与活性分析

近年的研究表明, 口蹄疫病毒(FMDV)非结构蛋白(NSP)2C在区分灭活疫苗免疫动物与自然感染动物方面具有潜在的价值, 为了建立敏感性更高的鉴别诊断方法, 将截取了2C蛋白N-端和C-端的主要B细胞表位区和完整3AB蛋白基因组合后, 进行了原核表达, 得到了分子量约为47.6 kD的目的蛋白2C￠3AB。通过Western blotting分析证明, 表达产物能被FMDV感染动物阳性血清识别, 具有很好的反应性。以通过电泳纯化的目的蛋白作抗原进行间接ELISA检测不同来源的动物血清, 结果表明, 该抗原仅与感染动物血清具有很好的反应活性, 而与健康动物与免疫动物血清无反应, 说明重组蛋白2C￠3AB可作为区分灭活疫苗免疫动物与感染动物的鉴别诊断抗原。用2C￠3AB和3ABC为抗原进行间接ELISA, 对比检测田间血清样品, 结果显示2C￠3AB-ELISA敏感性比3ABC-ELISA高。说明以重组蛋白2C￠3AB作为鉴别诊断抗原, 能进一步提高对临界值血清的检出率, 这对区分灭活疫苗免疫动物与FMDV隐性感染动物与带毒动物具有非常重要的意义。     

口蹄疫病毒非结构蛋白3AB 的原核表达及应用

旨在建立一种检测口蹄疫病毒非结构蛋白抗体的敏感、特异的ELISA方法。克隆、表达了口蹄疫病毒非结构蛋白3AB基因,原核表达的重组蛋白经亲和层析法纯化及Western blotting鉴定后作为包被抗原,建立检测口蹄疫病毒非结构蛋白抗体的3AB间接ELISA方法,通过与商品化试剂盒3ABC-ELISA的比对试验对其进行评价。结果显示,重组蛋白3AB以包涵体形式表达;能与口蹄疫病毒感染血清发生特异性反应,而不能与疫苗免疫动物血清发生反应;在检测田间样品时,与3ABC-ELISA具有同样的特异性和敏感性 (P＞     

抗丙肝病毒NS5蛋白单克隆抗体的研制及鉴定

用基因重组的丙肝病毒 ＮＳ５蛋白免疫Ｂａｌ ｂ／ｃ ／小鼠,制备免疫脾Ｂ淋巴细胞,与小鼠骨髓瘤Ｓｐ２／０细胞系融合,筛选获得了１株能分泌抗 ＮＳ５蛋白单克隆抗体的杂交瘤细胞株,该株单克隆抗体为 ＩｇＧ１。ＥＬＩＳＡ及 Ｗｅｓｔｅｒｎ Ｂｌｏｔ证实该株单抗对 ＮＳ５蛋白有较好的特异性。     

EB病毒早期蛋白P54的原核表达及其免疫原性的研究

PCR法获得编码EB病毒早期蛋白P54的基因BMRFl,序列分析后亚克隆入原核表达载体pET30a。表达质粒pET30a-BMRF1在大肠杆菌BL21(DE3)菌株中经IPTG诱导后表达了P54抗原,SDS—PAGE表明其相对分子质量为51000;采用镍离子亲和柱纯化重组蛋白。Western印迹结果表明纯化蛋白免疫BALB／c小鼠后产生了P54特异性抗体。间接免疫荧光表明免疫血清可以识别激活的Raji细胞中表达的P54蛋白。以上结果表明构建了原核表达质粒pET30a-BMRF1并在大肠杆菌细胞中成功表达EB病毒早期蛋白P54,表达蛋白具有很好的抗原性和免疫原性。     

人星状病毒Ⅰ型非结构蛋白nsP1a及其C末端蛋白nsP1a/4的原核表达及鉴定

人星状病毒(Human Astrovirus,HastV)是导致婴幼儿腹泻的重要病原体。HastV非结构蛋白nsP1a及C末端蛋白nsP1a/4含有各种保守的功能结构域,在星状病毒的复制、转录,病毒与宿主的相互作用中起重要作用。为获得nsP1a及其nsP1a/4蛋白,为后续蛋白相关研究提供平台,本研究在E.coli系统中进行人星状病毒非结构蛋白nsP1a及nsP1a/4蛋白的表达并对表达产物进行鉴定。首先将nsP1a及nsP1a/4基因克隆入原核表达载体PGEX-4T-1,构建nsP1a及nsP1a/4蛋白融合表达质粒;在E.coli BL21(DE3)中进行IPTG诱导表达,摸索两种融合蛋白表达的最优条件并对表达蛋白进行免疫印迹鉴定。结果表明nsP1a蛋白在30℃,1mM IPTG诱导12h时,蛋白表达量达到最高;nsP1a/4蛋白在20℃,0.5mM IPTG诱导8h时,蛋白表达量达到最高。Western blot结果显示两种融合蛋白既可与nsP1a蛋白免疫血清发生特异性反应,也可被GST标签抗体所识别。本研究成功利用原核系统表达并鉴定了人星状病毒非结构蛋白nsP1a及其C末端蛋白nsP1a/4,为进一步研究星状病毒非结构蛋白的功能及病毒的致病机制奠定基础。     

麦二叉蚜体内病毒结合蛋白基因的克隆和原核表达

从麦二叉蚜体内克隆了一个DNA片段,经序列测定表明该片段全长为1647bp,编码548个氨基酸.与禾谷缢管蚜的病毒结合蛋白基因核苷酸同源性为92%,氨基酸的同源性为96%,从而认为这是病毒结合蛋白基因(GenBank登录号为AF434719).构建了该基因的原核表达载体pBVSG和pETSG,用pBVSG表达出63kD的非融合目的蛋白,用pETSG表达出69kD的融合蛋白,二者均有较高的表达量.以纯化的融合蛋白免疫家兔,制备了此病毒结合蛋白的抗血清,用琼脂双扩散法测定效价为1∶512.     

登革2型病毒非结构蛋白NS4B的原核表达、纯化及多克隆抗体制备

目的：原核表达、纯化登革2型病毒非结构蛋白NS4B,并制备其多克隆抗体,以研究其结构与功能。方法：扩增编码登革2型病毒NS4B的24-238位氨基酸残基的基因序列,并将其克隆到原核表达载体pGEX-4T-1,转化大肠杆菌BL21（DE3）,IPTG诱导表达;采用蛋白浸提方法从SDS-PAGE胶中回收融合蛋白;用纯化后的融合蛋白免疫BALB／c鼠制备多克隆抗体,采用间接免疫荧光法检测抗体效价。结果：原核表达了NS4B-GST融合蛋白,并获得了其多克隆抗体,抗体效价为1：800。结论：登革2型病毒NS4B的24-238位氨基酸残基可诱导小鼠产生具有较高效价和特异性的多克隆抗体,这为研究NS4B的结构与功能奠定了基础。     

Generation of monoclonal antibodies against non-structural protein 3AB of foot-and-mouth disease virus

To identify linear epitopes on the non-structural protein 3AB of foot-and-mouth disease virus (FMDV), BABL/c mice were immunized with the 3AB protein and splenocytes of BALB/c mice were fused with myeloma Sp2/0 cells. Two hybridoma monoclonal antibodies (mAbs) cell lines against the 3AB protein of foot-and-mouth disease virus (FMDV) were obtained, named C6 and E7 respectively. The microneutralization titer was 1:1024 for mAb C6, and 1:512 for E7. Both mAbs contain kappa light chains, and were of subclass IgG2b. In order to define the mAbs binding epitopes, the reactivity of these mAbs against FMDV were examined by indirect ELISA. The results showed that both mAbs can react with FMDV, but had no cross-reactivity with Swine Vesicular Disease (SVD) antigens. The titers in abdomen liquor were 1:5×10⁶ for C6 and 1:2×10⁶ for E7. In conclusion, the mAbs obtained from this study are specific for the detection of FMDV, can be used for etiological and immunological researches on FMDV, and have potential use in diagnosis and future vaccine designs.     

Expression and purification of the outer shell proteinVP2 of the 4th serotype Bluetongue virus,and preparation of monoclonal antibodies against this protein

Bluetongue (BT) is an arbovirus transmitted disease by bites of the genus Culicoides and infects wild and domestic ruminants particularly in sheep. As an important outer shell protein which defines BTV serotypes, VP2 has been shown to be an ideal target antigen for identification of different BTV serotypes. In order to prepare a monoclonal antibody (mAb) against the VP2 protein of BTV-4, the corresponding encoding gene L2 was divided into three segments and then cloned into pET-28a (+) and pMAL-c5X vectors to generate recombinant plasmids, which were expressed in Escherichia coli BL21 (DE3) as histidine (His)-tagged (His-4A/4B/4C) and maltose-binding protein (MBP)-tagged (MBP-4A/4B/4C) fusion proteins. After affinity purification of His-4A/4B/4C with Ni-NTA agarose and MBP-4A/4B/4C with amylose resin, His-4A/4B/4C were used to immunize BALB/mice and MBP-4A/4B/4C were used to screen for mAb-secreting hybridomas. Five hybridoma cell lines stably secreting mAbs against different VP2 segments were obtained, in which 4A-1G7 and 4B-1B6 could recognize BTV-4 and also cross-react with other BTV serotypes. With the joint action of the two mAbs, BTV-4 and BTV-20 infection would be distinguished from other BTV serotypes. The successful preparation of recombinant VP2 segments and mAbs provides valuable materials that can be used in serological diagnosis of BTV-4.     

Preparation and characterization of monoclonal antibodies against VP1 protein of foot-and-mouth disease virus O/China99

Monoclonal antibodies (McAbs) 1A9 and 9F12 against Foot-and-mouth disease virus (FMDV) serotype O were produced by fusing SP2/0 myeloma cells with splenocyte from the mouse immunized with O/China99. Both McAbs reacted with O/China99 but not with Asia 1, as determined by immunohistochemistry assay. The microneutralization titer of the McAbs 1A9 and 9F12 were 640 and 1 280, respectively. Both McAbs contain kappa light chains, but the McAbs 1A9 and 9F12 were IgG1 and IgM, respectively. In order to define the McAbs binding epitopes, the reactivity of these McAbs against VP1, P20 and P14 were examined using indirect ELISA, the result showed that both McAbs reacted with VP1 and P20. McAbs may be used for further studies of vaccine, diagnostic methods, prophylaxis, etiological and immunological researches on FMDV.     

戊型肝炎病毒基因 ORF3编码蛋白在大肠杆菌中的表达及鉴定

实验以两种不同的表达策略构建了两个以大肠杆菌DE3为宿主的原核表达载体,由T7启动子启动外源基因的转录,在诱导剂IPTG诱导下成功地进行了戊肝病毒ORF3蛋白的原核表达。并通过SDS-聚丙烯酰胺凝胶电泳、免疫印迹、竞争抑制法酶联免疫等一系列实验对两种表达产物进行了鉴定和分析。综合分析两种表达结果发现,在融合型表达中ORF3蛋白与其融合标签蛋白(谷胱甘肽S一转移酶)之间存在免疫交叉反应,而且这种融合标签蛋白在空间结构上可能对ORF3蛋白中的抗体结合位点有掩盖作用。     

关于脑心肌炎病毒2A蛋白的研究进展

脑心肌炎病毒(Encephalomyocarditis virus,EMCV)是一种无囊膜的单股RNA病毒,属于小RNA病毒科,能够引起多种哺乳动物乃至人的感染。其非结构蛋白2A是重要的毒力因子,能够通过阻断翻译起始复合物的形成、结合翻译起始复合物因子及核糖体40s小亚基等方式竞争性地抑制宿主细胞蛋白的合成,还可通过抑制宿主细胞凋亡促进病毒扩散,并通过激活NF-κB引起宿主发生强烈的炎症反应[1]。此外,根据EMCV 2A蛋白的生物学特性,近年来,细胞生物学、病毒学领域均将其作为真核细胞与病毒互作的生物学工具展开了深入研究。     

Application of GP5 protein to develop monoclonal antibody against porcine reproductive and respiratory syndrome virus

In this study,a panel of monoclonal antibodies (mAbs) against Porcine reproductive and respiratory syndrome virus(PRRSV),named as 8C9 and4B4,were produced by fusing SP2/0 myeloma cells and spleen cells of BALB/c mice immunized with the PRRSV (TCID50=5.5),screened by the indirect ELISA and subjected to several limiting dilutions.mAbs were then identified by biological characterization.Among the two fusion cell strains,8C9 belonged to the IgG1 subclass and 4B4 belonged to the IgG2a subclass.The titers in cell culture supernatant and abdomen liquor reached to 1:104and 1:105,respectively.The specificity test indicated that the two cells had specific reactions for the PRRSV and GP5 protein respectively,and no reaction with Classical swine fever virus (CSFV) or Swine vesicular disease virus (SVDV).The molecular weights of the heavy chain and light chain were about 45.0 kDa and 25.0 kDa,respectively.In neutralization activity tests,the results showed that the prepared mAb 4B4 can protect 50% of cells with no CPE in dilution up to 1:512,but mAB 8C9 has no neutralization activities to PRRSV.     

呼吸道合胞病毒F蛋白抗体的研究进展

呼吸道合胞病毒(respiratory syncytial virus,RSV)感染,是造成婴幼儿、学龄前儿童、免疫缺陷患者、老年人等高危群体住院治疗及死亡的重要病因。目前,多个预防RSV感染的候选疫苗正处于研发中,尚无安全、有效的疫苗面世。对RSV感染的处理仍以治疗为主,使用帕利珠单抗(Palivizumab)是当前仅有的预防药物。在过去数年间出现的新型抗体药物,如多克隆抗体、单克隆抗体、纳米抗体等有些已进入了临床前或I、II、III期临床试验阶段。融合蛋白(fusion protein,F蛋白)在RSV感染过程中是不可或缺的,它介导病毒包膜与宿主细胞膜的融合。在感染过程中,F蛋白从亚稳态的融合前构象状态(prefusion fusion protein,pre F)转变为热力学稳定的融合后状态(postfusion fusionprotein,post F)。近年来,研究人员通过不断筛选,获得了多株针对pre F的抗体。与结合post F的抗体相比,这些抗体具有更强的RSV中和活性。一些更新的抗体药物候选品,在实验中显示出了效力强、药代动力学特征明显、半衰期长等特点,并能以其他途径给药,而且能降低其制备成本。现就抗RSV pre F的抗体研究进展作一概述。